Rheumatic Fever
Recent clinical, regulatory, research and industry developments relating to this disease.
Guidelines on the management of valvular heart disease (version 2012).
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
Clinical trials
The current development programme across all trial phases.
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Major themes1
- Heart Valve Prosthesis1
Leading journals2
- Circulation1
- European heart journal1
Leading researchers8
- Alfieri O1
- Andreotti F1
- Antunes MJ1
- Baddour LM1
- Baltimore RS1
- Barón-Esquivias G1
- Baumgartner H1
- Bolger A1
Affiliations (unnormalised)2
- Hospital Bichat AP-HP1
- Mayo Clinic1
Reference
Authoritative identity, definition & identifiers.
A febrile disease occurring as a delayed sequela of infections with STREPTOCOCCUS PYOGENES. It is characterized by multiple focal inflammatory lesions of the connective tissue structures, such as the heart, blood vessels, and joints (POLYARTHRITIS) and brain, and by the presence of ASCHOFF BODIES in the myocardium and skin.
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.